Literature DB >> 33344290

Rare occurrence of uterine arteriovenous malformation clinically mimicking a malignant growth: A critical reminder for pathologists.

Trang K Lollie1, Steven S Raman2, Amir Qorbani1,3, Ted Farzaneh1,4, Neda A Moatamed1.   

Abstract

Arteriovenous malformation (AVM) is a rare lesion in the uterus, which can lead to abnormal uterine bleeding. While AVM has been described in other organs in the literature, there is a paucity of pathology reports of the AVM in uterus. On gross examination, the uterus was markedly enlarged and partly distorted with a pedunculated solid mass, which on the cut surface showed multiple well-circumscribed hemorrhagic cysts ranging from 0.1 to 4.0 cm in size. Microscopically, they were malformed dilated vascular structures containing organized thrombi. We present this case of uterine AVM with gross and microscopic findings, which can serve as a crucial reminder for pathologists to keep in the differential diagnoses as a potential cause of abnormal uterine bleeding. Autopsy and Case Reports. ISSN 2236-1960.
Copyright © 2020.

Entities:  

Keywords:  Arteriovenous Malformations; Pathology; Uterine Hemorrhage; Uterus

Year:  2020        PMID: 33344290      PMCID: PMC7703198          DOI: 10.4322/acr.2020.144

Source DB:  PubMed          Journal:  Autops Case Rep        ISSN: 2236-1960


INTRODUCTION

Uterine arteriovenous malformation (AVM) is a rare and potentially fatal source of uterine bleeding due to abnormal vascular connections between arteries and veins. While the prevalence is unknown due to limited reported cases, an observational study on 265 patients with abnormal premenopausal bleeding showed an incidence of 3.4% by ultrasound. Uterine AVMs typically present in women of reproductive age; however, they can infrequently appear after menopause. Accurate preoperative radiological and clinical diagnosis is critical since uterine instrumentation used for abnormal uterine bleeding workups can inadvertently result in massive hemorrhage. When the preoperative diagnosis is inconclusive, intraoperative consultation can be a powerful tool to help guide surgical management. Thus, we describe a unique case report of a 58-year-old woman with postmenopausal bleeding in the setting of an unknown history of uterine AVM.

CASE REPORT

A 58-year-old gravida 2 para 2 morbidly obese woman with a history of severe chronic obstructive pulmonary disease (COPD), pulmonary hypertension, and congestive hepatopathy was referred to our institution for atypical profuse postmenopausal bleeding along with the imaging studies. The pregnancies were delivered at full term; the first via spontaneous vaginal delivery and the second via caesarian section followed by tubal ligation. There was no history of miscarriages or molar pregnancies and had had no curettage procedures. She was previously hospitalized at an outside institution for severe anemia requiring 8 units of red blood cells transfusions three months prior to the surgery. Pelvic ultrasound visualized an enlarged (16 cm) uterus with an 11 cm right-sided fundal mass and 3-mm-thickened endometrium. Follow up magnetic resonance imaging (MRI) re-demonstrated the 11 cm heterogeneous isointense and hyperintense solid mass with peripheral cystic regions concerning for leiomyosarcoma or a degenerating fibroid (Figure 1A). There were multiple smaller isointense and heterogeneous hyperintense uterine masses including a 4.1 cm heterogeneous cervical mass. Multiple endometrial biopsies were negative for hyperplasia or malignancies. While outside workup was inconclusive for the etiology of her bleeding, she was treated with Megestrol Acetate with incomplete resolution of her symptoms.
Figure 1

Pelvic MRI - T2 weighed images. A – Sagittal view of a pedunculated right uterine mass with enlarged gonadal artery and vein (arrows); B – Axial view of the dilated left uterine artery and vein with tortuous vessels surrounding cervix (arrows).

Upon current admission, the patient was afebrile and hemodynamically stable. Physical examination was notable for a 10-weeks anteverted uterus with a small amount of blood at the external cervical orifice. There was no lymphadenopathy. The remainder of the exam was unremarkable. There was no evidence of metastatic disease on chest imaging. Although, the three‐dimensional computed tomography (CT) angiography could have helped to assess the condition for a non-surgical intervention, the patient desired a definitive surgical management in view of the extensive bleeding. Hysterectomy with intraoperative consultation was pursued due to a high clinical suspicion of a malignant process. Procedural imaging findings revealed a large uterine mass perfused by perforator feeder vessels invading into the retroperitoneal space along with an irregular cervical mass heavily interlaced with uterine vessels (Figure 1B). While the exact diagnosis was not completely known at the time of intraoperative consultation, there were no overt features of malignancy. At the time of surgery, a frozen section diagnosis of a spindle cell lesion with atypia, but no overt malignancy, was rendered. After discussion with the surgeon and given the findings, the decision was made to proceed with hysterectomy and bilateral salpingo-oophorectomy. Weighing the risks and benefits in the setting of the patient's comorbidities including morbid obesity, no lymphadenectomy was carried out. Her post-operative course was complicated by increased oxygen requirements from advance stages of COPD and incision site infection. Her condition stabilized and she was discharged on postoperative day 7. She continued to do well at her two-month follow-up visit with complete resolution of the symptoms.

PATHOLOGICAL FINDINGS

Gross examination assessment documented an enlarged 812 grams (mean reference range 110g), severely distorted uterus with a prominent 11 cm right posterior pedunculated solid mass (Figure 2A). Sectioning revealed a tan-grey firm cut surface with multiple well-circumscribed hemorrhagic cysts ranging in size from 0.1 to 4.0 cm in diameter that distorted the myometrium (Figure 2B). No areas of gross necrosis or calcifications were identified. Extensive histological sampling showed a moderately cellular lesion consisting of bland spindled cells with no evidence of cellular atypia, mitosis, or necrosis. The remainder of the specimen was submitted for permanent section review, where the uterus and cervical masses were further extensively sampled.
Figure 2

Gross view of the A – Fresh total hysterectomy mass showing enlarged and deformed uterus; B – A cut surface through formalin-fixed specimen displaying multi-locular nature of the mass some containing clotted blood (dark loculi).

Histological examination of the uterine and cervical masses elucidated an abnormal evolution of bland endothelial cells into malformed arteries and venules with abrupt changes in, medial wall thickness, and abnormal vascular dilation highlighted by the trichrome and elastic stains (Figures 3A - 3C). The bland spindle cells lacked cytological atypia, mitosis, or necrosis. In areas of thrombus formation, there were many areas of intravascular papillary endothelial hyperplasia highlighted by ERG immunohistochemical (IHC) stain (Figures 33E). HMB45 and smooth muscle actin IHC stains were negative which ruled out angioleiomyoma. The final pathology diagnosis of uterine AVM was made.
Figure 3

Photomicrographs of the lesion. A – Hematoxylin & eosin (H&E) stain showing an abnormally dilated blood vessel filled with blood-clot (right lower quadrant). There are blood vessels of different size and wall-thickness throughout the field; B – Masson trichrome stain of the same area, as in the H&E photomicrograph, showing the proliferated blood vessels in a fibro-muscular background; C – Verhoeff elastic stain displaying the vessels including arteries and venules with abrupt changes in thickness of the medial, elastic layers of vessels, and vascular luminal sizes; D – H&E stain showing intravascular papillary endothelial hyperplasia (Masson bodies). Background is significant for hemorrhage and congestion; E – ERG immunohistochemical stain shows the endothelial cells covering the Masson bodies (A-D: 2x, E: 10x objectives).

DISCUSSION

Uterine AVMs are extremely rare and should be considered in the setting of persistent heavy uterine bleeding. Uterine AVMs are either acquired or, less commonly, developed congenitally. Acquired arteriovenous malformations stem from improper shunting of blood between intramural arterial branches and venous plexus as a result of uterine trauma. The most common iatrogenic causes are uterine surgical intervention such as caesarean section, myomectomy, or normal vaginal surgery. , Less frequently, they can arise from gestational trophoblastic disease, endometrial malignancies, intrauterine devices, infections, or fibroids. In contrast, congenital AVMs are caused by abnormal vascular connections originating from defects during embryological differentiation and angiogenesis. , The vessels often extend into the pelvis with the involvement of pelvic feeder vessels. These defects are diagnosed earlier in women of reproductive age. In this case, cesarean section was most likely the underlying etiology of our patient’s uterine AVM. Historically, AVMs were diagnosed post-operatively during pathological examination of the hysterectomy specimen. Fortunately, increasing availability and advances in imaging modalities has allowed for earlier detection of uterine AVMs. Ultrasound with Doppler and Spectral analysis is the initial diagnostic tool to detect abnormal vascularity within the myometrium. MRI and computed tomography (CT) are noninvasive approaches to confirm vascular abnormalities in conjunction with soft tissue assessment. Digital subtraction CT angiography is currently the gold standard for diagnostic confirmation with the additional benefit of feeder vessels identification for embolization. , The differential diagnoses for the uterine hypervascular lesions include retained products of conception, gestational trophoblastic diseases, and malignancies; thus, radiographic interpretation can be challenging. Surgical management of uterine AVMs depends on multiple factors including hemodynamic stability, the desire of fertility, site and size of the lesion, and age. Uterine artery embolization is an effective first-line therapy for those who wish to preserve fertility. Hysterectomy is reserved for those who do not desire to preserve fertility, life-threatening hemodynamic instability, and failure of embolization therapies. Pharmacological approaches including methylergonovine, gonadotropin-releasing hormone agonists, and danazol can be considered in hemodynamically stable patients. Uterine AVMs and leiomyosarcomas are rare entities that can cause postmenopausal bleeding. Histologically, leiomyosarcoma is a malignant infiltrative proliferation of spindled cells with characteristic smooth muscle differentiation. Surgical management includes radical hysterectomy and lymph node staging. In contrast, uterine AVMs have structural abnormalities of arteries and venules, resulting in a proliferation of bland appearing spindled endothelial cells in the varying wall thickness that lack cytological atypia, mitosis, or necrosis. The varied-wall thickness can be highlighted using trichome and Verhoeff elastic stains. Differentiation between arteries and veins is difficult due to secondary venule intimal wall thickening from increased intraluminal pressure. Menorrhagia and metrorrhagia are the most common symptoms of acquired uterine AVMs due to high vascular flow through the altered arterial-venous differential pressure gradient. Furthermore, congestive heart failure secondary to uterine AVMs has been reported. In this case, the patient’s uterine AVM contributed to high cardiac demand, which in turn exacerbated her pulmonary hypertension and congestive hepatopathy. This case report highlights the diagnostic difficulty of uterine AVMs and the importance of intraoperative consultation for unknown causes of abnormal postmenopausal uterine bleeding. Preoperative outside imaging interpretation favored a differential of leiomyosarcoma or degenerating fibroids. The concern for a sarcomatous process prompted extensive sampling of the uterus. However, frozen section examination demonstrated a bland spindled appearance with no evidence of cytological atypia, necrosis, or mitosis. On frozen sections, we were fairly certain that the lesion was not malignant histologically, however, we were uncertain about adequate sampling. Effective communication and astute clinical assessment prevented a radical hysterectomy, which might have included lymph node staging.

CONCLUSION

This case is a vivid example which teaches us that there are occasions when a lesion presents as a malignant growth clinically, but in fact, it may be a benign condition. When at an intraoperative consultation, the pathologist should be careful not to be swayed toward a malignant diagnosis by the surgeon and rely on her/his objective pathology findings.
  20 in total

1.  Progressive formation of uterine arteriovenous fistula after laparoscopic-assisted myomectomy.

Authors:  Akihiro Takeda; Kazuyuki Koyama; Sanae Imoto; Masahiko Mori; Kotaro Sakai; Hiromi Nakamura
Journal:  Arch Gynecol Obstet       Date:  2009-02-18       Impact factor: 2.344

Review 2.  Uterine arteriovenous malformations: a review of the current literature.

Authors:  Rosalie M Grivell; Kym M Reid; Amy Mellor
Journal:  Obstet Gynecol Surv       Date:  2005-11       Impact factor: 2.347

3.  Congenital arteriovenous malformations involving the pelvis and retroperitoneum: a case report.

Authors:  T Ishikawa
Journal:  Angiology       Date:  1979-01       Impact factor: 3.619

4.  Vascular malformations in the uterus: ultrasonographic diagnosis and conservative management.

Authors:  D Timmerman; T Van den Bosch; K Peeraer; E Debrouwere; D Van Schoubroeck; L Stockx; B Spitz
Journal:  Eur J Obstet Gynecol Reprod Biol       Date:  2000-09       Impact factor: 2.435

5.  Novel image-guided management of a uterine arteriovenous malformation.

Authors:  Stefan J Przybojewski; David J Sadler
Journal:  Cardiovasc Intervent Radiol       Date:  2010-08-06       Impact factor: 2.740

6.  Uterine arteriovenous malformations: primary treatment with therapeutic embolization.

Authors:  R L Vogelzang; A A Nemcek; Z Skrtic; J Gorrell; J R Lurain
Journal:  J Vasc Interv Radiol       Date:  1991-11       Impact factor: 3.464

Review 7.  Uterine arteriovenous malformation - diagnosis and management.

Authors:  Agata Szpera-Goździewicz; Karolina Gruca-Stryjak; Grzegorz H Bręborowicz; Mariola Ropacka-Lesiak
Journal:  Ginekol Pol       Date:  2018       Impact factor: 1.232

8.  Arteriovenous malformations of the uterus.

Authors:  H Fleming; A G Ostör; H Pickel; D W Fortune
Journal:  Obstet Gynecol       Date:  1989-02       Impact factor: 7.661

9.  A case with life-threatening uterine bleeding due to postmenopausal uterine arteriovenous malformation.

Authors:  Emi Sato; Kentaro Nakayama; Kohei Nakamura; Masako Ishikawa; Hiroshi Katagiri; Satoru Kyo
Journal:  BMC Womens Health       Date:  2015-02-17       Impact factor: 2.809

10.  A Systematic Review of Acquired Uterine Arteriovenous Malformations: Pathophysiology, Diagnosis, and Transcatheter Treatment.

Authors:  Daniel J Yoon; Megan Jones; Jamal Al Taani; Catalin Buhimschi; Joshua D Dowell
Journal:  AJP Rep       Date:  2015-10-12
View more
  3 in total

1.  Acquired uterine arterio-venous malformation post molar pregnancy suction-curettage: 2 case reports.

Authors:  A Lamrissi; A F Mabengui; M Mourabbih; M Jalal; K Fichtali; S Bouhya
Journal:  Int J Surg Case Rep       Date:  2022-04-25

2.  Arteriovenous Malformation of the Uterus in a 41-Year-Old Woman Presenting as Uterine Bleeding.

Authors:  Thomas Cotter; Ahmed Arfa; Pramila Moideen; Asad Ullah; Intisar Ghleilib
Journal:  Cureus       Date:  2022-03-30

3.  Retained Placenta Percreta with Acquired Uterine Arteriovenous Malformation-Case Report and Short Review of the Literature.

Authors:  Tudor Butureanu; Raluca Anca Balan; Razvan Socolov; Nicolae Ioanid; Demetra Socolov; Dumitru Gafitanu
Journal:  Diagnostics (Basel)       Date:  2022-04-05
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.